NCT07087262View on ClinicalTrials.gov

A Phase I Study of SNH-119014 in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL

Enrollment

96

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

March 28, 2026

Study Completion Date

March 28, 2026

Conditions

Hemoglobinopathy

Interventions

DRUG

SNH-119014

study drug

DRUG

Placebo

placebo

Trial Locations (1)

230601

RECRUITING

The Second Hospital of Anhui Medical University, Hefei

All Listed Sponsors

lead

ScinnoHub Pharmaceutical Co., Ltd.

INDUSTRY